EE200300553A - Piperidiinkarboksamiidi derivaadid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid - Google Patents

Piperidiinkarboksamiidi derivaadid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid

Info

Publication number: EE200300553A
Authority: EE; Estonia
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; carboxamide derivatives; piperidine carboxamide
Prior art date: 2001-05-21

Application number

EEP200300553A

Other languages

English (en)

Inventor

Emonds-Alt Xavier

Proietto Vincenzo

Original Assignee

Sanofi-Synthlabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-21

Filing date

2002-05-17

Publication date

2004-02-16

2002-05-17 Application filed by Sanofi-Synthlabo filed Critical Sanofi-Synthlabo

2004-02-16 Publication of EE200300553A publication Critical patent/EE200300553A/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Psychology (AREA)
Obesity (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Emergency Medicine (AREA)

EEP200300553A 2001-05-21 2002-05-17 Piperidiinkarboksamiidi derivaadid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid EE200300553A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0106691A FR2824828B1 (fr)	2001-05-21	2001-05-21	Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant
PCT/FR2002/001663 WO2002094821A1 (fr)	2001-05-21	2002-05-17	Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number	Publication Date
EE200300553A true EE200300553A (et)	2004-02-16

Family

ID=8863515

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300553A EE200300553A (et)	2001-05-21	2002-05-17	Piperidiinkarboksamiidi derivaadid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid

Country Status (36)

Country	Link
US (2)	US20040180890A1 (et)
EP (1)	EP1395582B1 (et)
JP (1)	JP2004529968A (et)
KR (1)	KR20030097886A (et)
CN (1)	CN1249059C (et)
AR (1)	AR035247A1 (et)
AT (1)	ATE294798T1 (et)
AU (1)	AU2002313065B2 (et)
BG (1)	BG108341A (et)
BR (1)	BR0209877A (et)
CA (1)	CA2445631A1 (et)
CZ (1)	CZ20033132A3 (et)
DE (1)	DE60204015T2 (et)
DK (1)	DK1395582T3 (et)
EA (1)	EA006236B1 (et)
EE (1)	EE200300553A (et)
ES (1)	ES2242032T3 (et)
FR (1)	FR2824828B1 (et)
HK (1)	HK1060129A1 (et)
HR (1)	HRP20030923A2 (et)
HU (1)	HUP0401563A2 (et)
IL (1)	IL158660A0 (et)
IS (1)	IS7008A (et)
MA (1)	MA27022A1 (et)
MX (1)	MXPA03010133A (et)
NO (1)	NO20035163D0 (et)
NZ (1)	NZ529206A (et)
PL (1)	PL367341A1 (et)
PT (1)	PT1395582E (et)
SK (1)	SK14192003A3 (et)
TN (1)	TNSN03118A1 (et)
TW (1)	TWI258480B (et)
UA (1)	UA75400C2 (et)
WO (1)	WO2002094821A1 (et)
YU (1)	YU86603A (et)
ZA (1)	ZA200308344B (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1569931B1 (en)	2002-12-13	2008-10-08	Smithkline Beecham Corporation	Heterocyclic compounds as ccr5 antagonists
FR2873373B1 (fr) *	2004-07-23	2006-09-08	Sanofi Synthelabo	Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique
CA2641817A1 (en) *	2006-02-01	2007-08-09	Solvay Pharmaceuticals Gmbh	Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparation
US20070219214A1 (en) *	2006-02-01	2007-09-20	Solvay Pharmaceuticals Gmbh	Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation
FR2912058A1 (fr) *	2007-02-07	2008-08-08	Sanofi Aventis Sa	Utilisation d'un compose antagoniste des recepteurs nk2 de la neurokinine a pour la preparation de medicaments utiles pour la prevention et le traitement des dysfonctions sexuelles
EP2244716B1 (en) *	2008-01-11	2019-09-25	United Paragon Associates Inc.	Fertilized egg isolate and use thereof
US20110152233A1 (en) *	2009-12-18	2011-06-23	Henner Knust	Pyrrolidine compounds
KR101756495B1 (ko) *	2010-03-11	2017-07-10	다이닛본 스미토모 세이야꾸 가부시끼가이샤	Ｎ-아실 시클릭 아민 유도체 또는 이의 의약상 허용되는 염
WO2015200594A2 (en)	2014-06-25	2015-12-30	Emory University	Methods of managing conditioned fear with neurokinin receptor antagonists
CN113194948A (zh) *	2018-11-15	2021-07-30	国立大学法人九州大学	Il-31介导性疾病的预防或治疗剂及医药组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5689663A (en) *	1992-06-19	1997-11-18	Microsoft Corporation	Remote controller user interface and methods relating thereto
US5780466A (en) *	1995-01-30	1998-07-14	Sanofi	Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present
FR2729954B1 (fr) *	1995-01-30	1997-08-01	Sanofi Sa	Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2738819B1 (fr) *	1995-09-14	1997-12-05	Sanofi Sa	Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant
HU224225B1 (hu) *	1995-12-01	2005-06-28	Sankyo Co. Ltd.	Tachikinin receptor antagonista hatású heterociklusos vegyületek, ezek előállítási eljárása és alkalmazásuk gyógyszerkészítmények előállítására
JP3192631B2 (ja) *	1997-05-28	2001-07-30	三共株式会社	飽和複素環化合物からなる医薬
PL341013A1 (en) *	1997-12-04	2001-03-12	Sankyo Co	Acylated heteroalicyclic derivatives
AU1684300A (en) *	1998-12-10	2000-06-26	Sankyo Company Limited	Cyclohexylpiperidine derivatives
FR2791346B3 (fr) *	1999-03-25	2001-04-27	Sanofi Sa	Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant

2001
- 2001-05-21 FR FR0106691A patent/FR2824828B1/fr not_active Expired - Fee Related
2002
- 2002-05-17 CA CA002445631A patent/CA2445631A1/fr not_active Abandoned
- 2002-05-17 DK DK02738257T patent/DK1395582T3/da active
- 2002-05-17 BR BR0209877-6A patent/BR0209877A/pt not_active IP Right Cessation
- 2002-05-17 YU YU86603A patent/YU86603A/sh unknown
- 2002-05-17 WO PCT/FR2002/001663 patent/WO2002094821A1/fr active IP Right Grant
- 2002-05-17 IL IL15866002A patent/IL158660A0/xx not_active IP Right Cessation
- 2002-05-17 UA UA2003109761A patent/UA75400C2/uk unknown
- 2002-05-17 HU HU0401563A patent/HUP0401563A2/hu unknown
- 2002-05-17 EA EA200301087A patent/EA006236B1/ru not_active IP Right Cessation
- 2002-05-17 PL PL02367341A patent/PL367341A1/xx not_active Application Discontinuation
- 2002-05-17 SK SK1419-2003A patent/SK14192003A3/sk unknown
- 2002-05-17 US US10/477,682 patent/US20040180890A1/en not_active Abandoned
- 2002-05-17 PT PT02738257T patent/PT1395582E/pt unknown
- 2002-05-17 TN TNPCT/FR2002/001663A patent/TNSN03118A1/fr unknown
- 2002-05-17 AU AU2002313065A patent/AU2002313065B2/en not_active Ceased
- 2002-05-17 EE EEP200300553A patent/EE200300553A/et unknown
- 2002-05-17 ES ES02738257T patent/ES2242032T3/es not_active Expired - Lifetime
- 2002-05-17 CZ CZ20033132A patent/CZ20033132A3/cs unknown
- 2002-05-17 AT AT02738257T patent/ATE294798T1/de not_active IP Right Cessation
- 2002-05-17 DE DE60204015T patent/DE60204015T2/de not_active Expired - Fee Related
- 2002-05-17 EP EP02738257A patent/EP1395582B1/fr not_active Expired - Lifetime
- 2002-05-17 CN CNB028124529A patent/CN1249059C/zh not_active Expired - Fee Related
- 2002-05-17 KR KR10-2003-7015099A patent/KR20030097886A/ko active IP Right Grant
- 2002-05-17 MX MXPA03010133A patent/MXPA03010133A/es active IP Right Grant
- 2002-05-17 JP JP2002591494A patent/JP2004529968A/ja active Pending
- 2002-05-17 NZ NZ529206A patent/NZ529206A/en unknown
- 2002-05-20 TW TW091110506A patent/TWI258480B/zh not_active IP Right Cessation
- 2002-05-21 AR ARP020101870A patent/AR035247A1/es unknown
2003
- 2003-10-27 ZA ZA200308344A patent/ZA200308344B/en unknown
- 2003-10-30 IS IS7008A patent/IS7008A/is unknown
- 2003-11-10 BG BG108341A patent/BG108341A/bg unknown
- 2003-11-12 HR HR20030923A patent/HRP20030923A2/hr not_active Application Discontinuation
- 2003-11-14 MA MA27396A patent/MA27022A1/fr unknown
- 2003-11-20 NO NO20035163A patent/NO20035163D0/no not_active Application Discontinuation
2004
- 2004-05-04 HK HK04103130A patent/HK1060129A1/xx not_active IP Right Cessation
2008
- 2008-06-03 US US12/131,999 patent/US20080261976A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN1518549A (zh)	2004-08-04
ES2242032T3 (es)	2005-11-01
FR2824828A1 (fr)	2002-11-22
TNSN03118A1 (fr)	2005-12-23
EA200301087A1 (ru)	2004-04-29
TWI258480B (en)	2006-07-21
EP1395582A1 (fr)	2004-03-10
DK1395582T3 (da)	2005-08-29
IL158660A0 (en)	2004-05-12
AU2002313065B2 (en)	2007-06-28
DE60204015T2 (de)	2006-01-12
JP2004529968A (ja)	2004-09-30
ZA200308344B (en)	2004-10-27
PT1395582E (pt)	2005-08-31
MA27022A1 (fr)	2004-12-20
EA006236B1 (ru)	2005-10-27
CA2445631A1 (fr)	2002-11-28
IS7008A (is)	2003-10-30
SK14192003A3 (sk)	2004-06-08
UA75400C2 (en)	2006-04-17
NZ529206A (en)	2005-09-30
BG108341A (bg)	2004-12-30
US20040180890A1 (en)	2004-09-16
YU86603A (sh)	2006-05-25
ATE294798T1 (de)	2005-05-15
KR20030097886A (ko)	2003-12-31
FR2824828B1 (fr)	2005-05-20
NO20035163D0 (no)	2003-11-20
BR0209877A (pt)	2004-06-08
CN1249059C (zh)	2006-04-05
EP1395582B1 (fr)	2005-05-04
US20080261976A1 (en)	2008-10-23
DE60204015D1 (de)	2005-06-09
HK1060129A1 (en)	2004-07-30
AR035247A1 (es)	2004-05-05
HUP0401563A2 (hu)	2004-12-28
WO2002094821A1 (fr)	2002-11-28
CZ20033132A3 (cs)	2004-02-18
PL367341A1 (en)	2005-02-21
HRP20030923A2 (en)	2004-02-29
MXPA03010133A (es)	2005-03-31

Publication	Publication Date	Title
EE200200409A (et)	2003-12-15	1,3-dihüdro-2H-indool-2-ooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE200300054A (et)	2004-12-15	Kinaasi inhibiitoritena toimivad bitsüklopürasoolid, nende valmistamismeetod, kasutamine ja neid sisaldavad farmatseutilised kompositsioonid
EE05198B1 (et)	2009-08-17	Asendatud aminometlrhma sisaldavad N-(arlsulfonl)beetaaminohappe derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsi£onid
EE200000707A (et)	2002-04-15	Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE200300207A (et)	2003-08-15	Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
EE05081B1 (et)	2008-10-15	Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, 3-aminoasetidiini derivaadid ja nende valmistamise meetodid
EE05104B1 (et)	2008-12-15	Asetidiini derivaadid, nende valmistamise meetodid ja farmatseutiline kompositsioon
EE200300369A (et)	2003-10-15	Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
HU228253B1 (en)	2013-02-28	Substituted cyclohexane-1,4-diamine derivatives, process for their preparation and pharmaceutical compositions containing them
EE200300259A (et)	2003-08-15	Mandelhappe derivaadid, nende valmistamise meetod, nende kasutamine trombiini inhibiitoritena ja neid sisaldavad ravimkoostised
IL160108A0 (en)	2004-06-20	Pharmaceutical compositions containing beta-lapachone or derivatives or analogs thereof, and methods of using same
EE200200369A (et)	2003-10-15	Asendatud piperidiinid, neid ühendeid sisaldavad ravimid ja meetodid nende valmistamiseks
HUP0401499A3 (en)	2007-05-02	Indole derivatives as cox ii inhibitors, process for their preparation and pharmaceutical compositions containing them
DK1122254T3 (da)	2005-08-29	4-sulfonamidpiperidinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
EE05304B1 (et)	2010-06-15	Aminokinoliini derivaadid, meetod nende valmistamiseks, neid sisaldavad ravimkoostised ja nende kasutamine adenosiini A3-retseptori ligandidena
EE200300553A (et)	2004-02-16	Piperidiinkarboksamiidi derivaadid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid
EE05004B1 (et)	2008-04-15	Aminotiasooli derivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid
EE200400022A (et)	2004-04-15	Pürrolidiinoksadiasooli ja -tiadiasooli derivaadid, nende valmistamise meetod ja neid sisaldavad ravimkoostised
HUP0204001A3 (en)	2005-04-28	Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0303105A3 (en)	2005-05-30	Novel aminocyclohexane derivatives, process for their preparation, pharmaceutical compositions containing them and their use
EE04437B1 (et)	2005-02-15	(1-fenatsüül-3-fenüül-3-piperidinüületüül)piperidiini derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
HUP0102895A3 (en)	2002-01-28	Cyclopentanone dihydropyridine derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
EE200100499A (et)	2002-12-16	Uued morfoliini derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
HUP0400207A3 (en)	2008-03-28	Substituted 4-aminocyclohexanol derivatives, process for their preparation and pharmaceutical compositions containing them
SI1245565T1 (en)	2003-12-31	Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date	Code	Title	Description
2005-02-15	HC1A	Change of owner name